LYEONS

📍 Cambridge, United Kingdom🗓 Founded 2024👥 15 employees💰 Last funded Aug 2026
Technology, Information and Media🌐 lyeons.com
Website LinkedIn
LYEONS is a neurotechnology company developing non-invasive, body-first solutions to support nervous system regulation and everyday neurohealth. Our technology uses gentle, heartbeat-like audio-tactile stimulation to provide the body with a physiological rhythm that may support calm, sleep, focus and resilience during moments of stress or overwhelm. Our first platform, the LYEONS Heart, is being developed through scientific research, human-centred design and ongoing collaboration with users, researchers and clinicians. Our work explores how sensory rhythms can influence physiological state, emotional regulation and cognitive performance. Our multidisciplinary team brings together expertise in neuroscience, engineering, clinical research, medical device development and lived experience. We are committed to translating promising neurotechnology into safe, accessible and meaningful solutions that people can use in everyday life. LYEONS is building a new generation of neurohealth technology at the intersection of neuroscience, physiology and human experience.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in LYEONS?
LYEONS has 1 investors on record on gritt.io, including 1 early-stage backers.
When did LYEONS last raise funding?
The most recent investment in LYEONS recorded on gritt.io was in August 2026.
When was LYEONS founded?
LYEONS was founded in 2024.
What industry is LYEONS in?
LYEONS operates in Technology, Information and Media. Find similar Technology, Information and Media investors on gritt.io.
Where is LYEONS based?
LYEONS is headquartered in Cambridge, United Kingdom.